Search

Your search keyword '"Bergmann K.C."' showing total 95 results

Search Constraints

Start Over You searched for: Author "Bergmann K.C." Remove constraint Author: "Bergmann K.C."
95 results on '"Bergmann K.C."'

Search Results

1. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

2. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

3. Comparison of two different pollen season definitions based on 10 years of birch and grass pollen data from two distant central European cities: An EAACI Task Force report.

5. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

6. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

9. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

10. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

12. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

13. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

14. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

15. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

16. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B<

17. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

18. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

19. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

20. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

21. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

22. 2019 ARIA Care pathways for allergen immunotherapy [ARIA-Versorgungspfade für die Allergenimmuntherapie 2019]

24. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

25. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

26. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

27. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

28. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS

29. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

30. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

31. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

32. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

33. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

34. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

35. Definition von Pollenexpositionszeiten für klinische Studien zur Allergen-Immuntherapie bei polleninduzierter Rhinokonjunktivitis – ein EAACI-Positionspapier

36. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: A SUNFRAIL report

37. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study

38. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

39. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: A SUNFRAIL report

40. Work productivity in rhinitis using cell phones: The MASK pilot study

41. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

42. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

43. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

44. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

45. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

47. Building bridges for innovation in ageing:synergies between action groups of the EIP on AHA

48. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation

49. WITHDRAWN: Scaling up strategies of the Chronic Respiratory Disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3 – Area 5)

50. Building bridges for innovation in ageing:synergies between action groups of the EIP on AHA

Catalog

Books, media, physical & digital resources